STOCK TITAN

WeRide schedules Q3 results review for Nov. 20, 2026

The earnings call will offer English and Chinese simultaneous interpretation, with the Chinese line available in listen-only mode.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

WeRide Inc. announced that its board will meet on November 20, 2026, to consider and approve the Group’s unaudited results for the three months ended September 30, 2026, and their publication. Management will hold a results call at 9:00 p.m. Beijing/Hong Kong Time or 8:00 a.m. U.S. Eastern Time on November 20. Participants may register for English or Chinese simultaneous interpretation; the Chinese line is listen-only, and a live and archived webcast will be available on WeRide’s investor relations website.

Board meeting November 20, 2026 The board will consider and approve quarterly results and their publication.
Results period end September 30, 2026 Three months ended September 30, 2026.
Earnings call time 9:00 p.m. Beijing/Hong Kong Time; 8:00 a.m. U.S. Eastern Time November 20, 2026
weighted voting rights technical
"controlled through weighted voting rights"
A system where some shares carry more voting power than others so certain owners can control corporate decisions with fewer shares. Think of it like tickets to a meeting where some tickets count for five votes and others for one: it lets founders or insiders steer strategy and board picks even if they don't own most of the stock. For investors this affects corporate governance, the protection of minority shareholders, and how much influence public holders have over major decisions.
unaudited quarterly results financial
"considering and approving the unaudited quarterly results"
simultaneous interpretation technical
"Chinese simultaneous interpretation options"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2026

 

Commission File Number: 001-42213

 

 

 

WeRide Inc.

 

 

 

21st Floor, Tower A, Guanzhou Life Science Innovation Center

No. 51, Luoxuan Road, Guangzhou International Biotech Island

Guangzhou 510005

People’s Republic of China

(Address of principal executive offices)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x Form 40-F ¨

 

 

 

 

 

 

EXPLANATORY NOTE

 

WeRide Inc. made an announcement dated November 6, 2026 with the Stock Exchange of Hong Kong Limited in relation to the date of board meeting. For details, please refer to the exhibit to this current report on Form 6-K.

 

 

 

 

EXHIBIT INDEX

 

Exhibit No.     Description  
99.1   Announcement – Date of Board Meeting

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  WeRide Inc.
     
  By: /s/ Jennifer Li
  Name: Jennifer Li
  Title: Chief Financial Officer

 

Date: November 6, 2026

 

 

Exhibit 99.1

 

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

 

WeRide Inc.

文遠知行*

(A company controlled through weighted voting rights and incorporated in the Cayman Islands with limited liability)

(Stock Code: 0800)

 

DATE OF BOARD MEETING

 

The board of directors (the “Board”) of WeRide Inc. (the “Company,” together with its subsidiaries, the “Group”) hereby announces that a meeting of the Board will be held on Friday, November 20, 2026 Beijing/Hong Kong Time, for the purposes of, among other things, considering and approving the unaudited quarterly results of the Group for the three months ended September 30, 2026 and its publication.

 

The Company’s management team will hold an earnings conference call at 9:00 P.M. Beijing/ Hong Kong Time on Friday, November 20, 2026 or at 8:00 A.M. U.S. Eastern Time on Friday, November 20, 2026 to discuss the results. Details for the conference call are as follows:

 

Event Title: WeRide Inc. Third Quarter 2026 Earnings Call

 

English Registration Link: https://register-conf.media-server.com/register/BIfea88546dc6b410cb55a66c8e874bc2e

 

Chinese Simultaneous Interpretation Registration Link (listen-only mode): https://register-conf.media-server.com/register/BI0566d324693c403dbc3fce728df2fc80

 

All participants are required to complete the online registration in advance using the links provided above. During the registration, participants may select either the English or Chinese simultaneous interpretation options. Please note that the Chinese simultaneous interpretation line will be available in listen-only mode. Upon successful registration, each participant will receive a confirmation email containing the relevant dial-in details and a unique access PIN, which can be used to join the conference call.

 

Additionally, a live and archived webcast of the conference call will be available on the Company’s investor relations website at https://ir.weride.ai.

 

  By Order of the Board
  WeRide Inc.
  Dr. Tony Xu Han
  Chairman of the Board, Executive Director
  and Chief Executive Officer

 

Hong Kong, November 6, 2026

 

As at the date of this announcement, the Board comprises Dr. Tony Xu Han and Dr. Yan Li as executive Directors, Mr. Ichijo Futakawa and Mr. Jean-François Salles as non-executive Directors, and Ms. Huiping Yan, Mr. David Zhang and Dr. Tony Fan-cheong Chan as independent non-executive Directors.

 

*       For identification purposes only

 

 

 

Filing Exhibits & Attachments

1 document

Keep reading